SR 47063

Known as: SR-47063, SR47063 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2010
0119942010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
ATP-sensitive K(+) (K(ATP)) channels are the target of a number of pharmacological agents, blockers like hypoglycemic… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2010
2010
The function of the ATP-sensitive potassium (K(ATP)) channel relies on the proper coupling between its two subunits: the pore… (More)
Is this relevant?
2006
2006
Persistent pulmonary hypertension of the newborn is a life-threatening condition in which half of infants fail to respond to… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2000
2000
The vasorelaxant effects of SR 47063 (4-(2-cyanimino-1, 2-dihydropyrid-1-yl)-2,2-dimethyl-6-nitr ochromene), a new K(+)-channel… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
1994
1994
(i) We studied the effects of a new cromakalim analogue, SR47063, in guinea-pig ventricular cells. The experiments were carried… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?